174 related articles for article (PubMed ID: 36583006)
21. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
Zhang G; Yu X; Liu P; Huang X; Jiang X
Dig Dis Sci; 2018 Dec; 63(12):3207-3219. PubMed ID: 30140982
[TBL] [Abstract][Full Text] [Related]
23. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
Zhang H; Gao C; Fang L; Zhao HC; Yao SK
Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
[TBL] [Abstract][Full Text] [Related]
24. Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP.
Tian Y; Tang B; Wang C; Sun D; Zhang R; Luo N; Han Z; Liang R; Gao Z; Wang L
Oncotarget; 2016 Jul; 7(29):46230-46241. PubMed ID: 27323827
[TBL] [Abstract][Full Text] [Related]
25. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
26. Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis.
Liu CQ; Sun JX; Xu JZ; Qian XY; Hong SY; Xu MY; An Y; Xia QD; Hu J; Wang SG
Front Pharmacol; 2022; 13():865988. PubMed ID: 35462910
[No Abstract] [Full Text] [Related]
27. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
28. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
29. Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching Analysis.
Jang WI; Kim MS; Lim JS; Yoo HJ; Seo YS; Han CJ; Park SC; Kay CS; Kim M; Jang HS; Lee DS; Chang AR; Park HJ
Anticancer Res; 2015 Sep; 35(9):5047-54. PubMed ID: 26254406
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.
Hydes TJ; Cuthbertson DJ; Graef S; Berhane S; Teng M; Skowronska A; Singh P; Dhanaraj S; Tahrani A; Johnson PJ
Clin Ther; 2022 Feb; 44(2):257-268. PubMed ID: 35078642
[TBL] [Abstract][Full Text] [Related]
31. The comparison of different antiviral therapies on the prognosis of hepatitis B virus-related hepatocellular carcinoma after curative treatments: A network meta-analysis.
Xia Z; He L; Xiong L; Wen T
Medicine (Baltimore); 2020 Aug; 99(33):e20877. PubMed ID: 32871973
[TBL] [Abstract][Full Text] [Related]
32. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
33. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
34. Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients.
Jung WJ; Jang S; Choi WJ; Park J; Choi GH; Jang ES; Jeong SH; Choi WS; Lee JH; Yoon CJ; Kim JW
Sci Rep; 2022 Aug; 12(1):14482. PubMed ID: 36008432
[TBL] [Abstract][Full Text] [Related]
35. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis.
Antwi SO; Li Z; Mody K; Roberts LR; Patel T
J Clin Gastroenterol; 2020; 54(5):468-476. PubMed ID: 32271517
[TBL] [Abstract][Full Text] [Related]
36. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
37. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
Vilar-Gomez E; Calzadilla-Bertot L; Wong VW; Castellanos M; Aller-de la Fuente R; Eslam M; Wong GL; George J; Romero-Gomez M; Adams LA
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):136-145.e6. PubMed ID: 32389886
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis.
Li J; Hernanda PY; Bramer WM; Peppelenbosch MP; van Luijk J; Pan Q
PLoS One; 2015; 10(6):e0127967. PubMed ID: 26030161
[TBL] [Abstract][Full Text] [Related]
39. Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.
Vilar-Gomez E; Vuppalanchi R; Desai AP; Gawrieh S; Ghabril M; Saxena R; Cummings OW; Chalasani N
Aliment Pharmacol Ther; 2019 Aug; 50(3):317-328. PubMed ID: 31157422
[TBL] [Abstract][Full Text] [Related]
40. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
Zeng S; Gan HX; Xu JX; Liu JY
Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
